LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay

Transplantation

Volumn 96, Issue 3, 2013, Pages 324-330

  Shankar, Nisha ^a   Daly, Richard ^b   Geske, Jennifer ^b   Kushwaha, Sudhir K ^b   Timmons, Michael ^b   Joyce, Lyle ^b   Stulak, John ^b   Gandhi, Manish ^b   Kremers, Walter ^b   Park, Soon ^b   Pereira, Naveen L ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Heart transplant; HLA; Left ventricular assist device; Single antigen bead assay

Indexed keywords

ADULT; ALLOSENSITIZATION; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNOASSAY; LEFT VENTRICULAR ASSIST DEVICE; MALE; PRIORITY JOURNAL; SENSITIZATION; SINGLE ANTIGEN BEAD ASSAY; SURVIVAL TIME;

ADULT; FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED;

EID: 84881611257     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182985371     Document Type: Article

References (17)

1. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: twentyeight adult heart transplant reportV2011. J Heart Lung Transplant 2011; 30: 1078.
2. Pak SW, Uriel N, Burke E, et al. High incidence of elevated panel reactive antibodies in patients supported with HeartMate II left ventricular assist devices. Circulation 2010; 122: A20395.
3. Ross H, Tinckam K, Rao V, et al. In praise of ventricular assist devicesVmechanical bridge to virtual crossmatch for the sensitized patient. J Heart Lung Transplant 2010; 29: 728.
4. Kobashigawa J, Mehra M, West L, et al. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant 2009; 28: 213.
5. Nwakanma LU,Williams JA,Weiss ES, et al. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg 2007; 84: 1556; discussion 1562Y1553.
6. Bishay ES, Cook DJ, Starling RC, et al. The clinical significance of flow cytometry crossmatching in heart transplantation. Eur J Cardiothorac Surg 2000; 17: 362.
7. Joyce DL, Southard RE, Torre-Amione G, et al. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on posttransplant outcomes. J Heart Lung Transplant 2005; 24: 2054.
8. Massad MG, McCarthy PM, Smedira NG, et al. Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome J Thorac Cardiovasc Surg 1996; 112: 1275; discussion 1282Y1273.
9. Newell H, Smith JD, Rogers P, et al. Sensitization following LVAD implantation using leucodepleted blood is not due to HLA antibodies. Am J Transplant 2006; 6: 1712.
10. Coppage M, Baker M, Fialkow L, et al. Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products. Hum Immunol 2009; 70: 413.
11. Drakos SG, Kfoury AG, Kotter JR, et al. Prior human leukocyte antigenallosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant 2009; 28: 838.
12. George I, Colley P, Russo MJ, et al. Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg 2008; 135: 1372.
13. Malickaite R, Rucinskas K, Staneviciene A, et al. Sensitisation and post-transplant course after the implantation of ventricular assist device. Interact Cardiovasc Thorac Surg 2009; 8: 339; discussion 342Y333.
14. Schuster M, Kocher A, John R, et al. B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression. Hum Immunol 2002; 63: 211.
15. Raichlin E, Al-Omari MA, Hayes CL, et al. Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation. J Heart Lung Transplant 2011; 30: 1153.
16. Gloor JM, DeGoey S, Ploeger N, et al. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation 2004; 78: 221.
17. Gandhi MJ, DeGoey SR, Bundy K, et al. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes. Transplant Proc 2011; 43: 3840.